107 related articles for article (PubMed ID: 8210886)
41. Clinical pharmaceutics and calcium-ceftriaxone.
Gin AS; Wheaton H; Dalton B
Ann Pharmacother; 2008 Mar; 42(3):450-1. PubMed ID: 18230702
[No Abstract] [Full Text] [Related]
42. The risk of taking ascorbic acid.
Fletcher RH
JAMA Intern Med; 2013 Mar; 173(5):375-94. PubMed ID: 23381657
[No Abstract] [Full Text] [Related]
43. [Abuse of laxatives and appendicular lithiasis. (Apropos of a case)].
LENOIR P; DELAHAYE RP; ISNARD J
Presse Med (1893); 1962 May; 70():1148-50. PubMed ID: 14464014
[No Abstract] [Full Text] [Related]
44. Ascorbic acid in nephrolithiasis: culprit or cure?
Weaver DF
Postgrad Med; 1983 May; 73(5):63, 66. PubMed ID: 6844178
[No Abstract] [Full Text] [Related]
45. Management of calcium oxalate stones.
Hanson KA
Clin Excell Nurse Pract; 2001; 5(1):21-5. PubMed ID: 11154390
[TBL] [Abstract][Full Text] [Related]
46. [Treatment of calcium kidney lithiasis. ESWL, NLP, open surgery].
Boronat Tormo F; Pontones Moreno JL; Broseta Rico E; Oliver Amoros F; Budia Alba A; Jimenez Cruz JF
Arch Esp Urol; 2001 Nov; 54(9):909-25. PubMed ID: 11789370
[TBL] [Abstract][Full Text] [Related]
47. [Metabolic investigation of calcium oxalate urinary lithiasis. Indicators of lithogenic risk: modalities, applications and perspectives].
Robert M
Prog Urol; 1996 Feb; 6(1):44-51. PubMed ID: 8624527
[TBL] [Abstract][Full Text] [Related]
48. Evaluation of lithogenic elements in urine of healthy newborns.
Cillo AC; Cattini H; Boim MA; Schor N
Pediatr Nephrol; 2001 Dec; 16(12):1080-3. PubMed ID: 11793105
[TBL] [Abstract][Full Text] [Related]
49. [Removal of staghorn calculi from the urinary tract with extracorporeal shock wave lithotripsy and endourologic treatment methods].
Zogović J; Mladenović Lj
Srp Arh Celok Lek; 1996; 124(11-12):323-7. PubMed ID: 9132970
[TBL] [Abstract][Full Text] [Related]
50. Safety considerations with high ascorbic acid dosage.
Barness LA
Ann N Y Acad Sci; 1975 Sep; 258():523-8. PubMed ID: 946
[No Abstract] [Full Text] [Related]
51. [Drug induced lithiases].
Daudon M; Estepa L
Presse Med; 1998 Apr; 27(14):675-83. PubMed ID: 9767927
[No Abstract] [Full Text] [Related]
52. Dosimetry considerations in the enhanced sensitivity of male Wistar rats to chronic ethylene glycol-induced nephrotoxicity.
Corley RA; Wilson DM; Hard GC; Stebbins KE; Bartels MJ; Soelberg JJ; Dryzga MD; Gingell R; McMartin KE; Snellings WM
Toxicol Appl Pharmacol; 2008 Apr; 228(2):165-78. PubMed ID: 18191429
[TBL] [Abstract][Full Text] [Related]
53. [Hereditary diseases causing kidney calculi].
Cochat P; Jouvenet M; Pellet H; Feber J; Martin X; Divry P
Rev Prat; 1997 Sep; 47(14):1554-8. PubMed ID: 9366114
[TBL] [Abstract][Full Text] [Related]
54. Protease inhibitor-induced urolithiasis.
Gentle DL; Stoller ML; Jarrett TW; Ward JF; Geib KS; Wood AF
Urology; 1997 Oct; 50(4):508-11. PubMed ID: 9338723
[TBL] [Abstract][Full Text] [Related]
55. [Medical treatment of uric acid lithiasis of the urinary tract and usefulness of double J catheter].
Granados Loarca EA
Arch Esp Urol; 2001 Mar; 54(2):157-61. PubMed ID: 11341120
[TBL] [Abstract][Full Text] [Related]
56. Uncovering magnesium toxicity.
Ratzan RM; Chapron DJ; Mumford D; Pitegoff G
Geriatrics; 1980 Sep; 35(9):75-8, 83-4, 86. PubMed ID: 7409484
[No Abstract] [Full Text] [Related]
57. Nephrolithiasis from calcium supplementation.
Pak CY; Sakhaee K; Hwang TI; Preminger GM; Harvey JA
J Urol; 1987 Jun; 137(6):1212-3. PubMed ID: 3586158
[No Abstract] [Full Text] [Related]
58. [Serum levels of vitamin C in young adults who chronically use drugs of abuse].
Márquez M; Rincón M; Sútil R; de Yépez CR; Saer R; Ponte S
Invest Clin; 2001 Sep; 42(3):183-94. PubMed ID: 11552507
[TBL] [Abstract][Full Text] [Related]
59. [The laxative disease].
Le Quintrec Y
Rev Prat; 1981 Sep; 31(41):2899-900, 2903-4, 2907-8. PubMed ID: 7291904
[No Abstract] [Full Text] [Related]
60. [Gout].
Gröbner W; Zöllner N
Z Rheumatol; 2004 Feb; 63(1):2-9. PubMed ID: 14991273
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
